Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
Cytokine
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Imlygic
(talimogene laherparepvec) / Amgen
Zaltrap
(ziv-aflibercept IV) / Sanofi
bintrafusp alfa
(M7824) / EMD Serono
Pexa-Vec
(pexastimogene devacirepvec) / SillaJen, Transgene
Actemra IV
(tocilizumab) / Roche, JW Pharma
